Coya Therapeutics, Common Stock Price on November 27, 2024
| COYA Stock | 6.52 0.13 1.95% |
If you're considering investing in Coya Stock, it is important to understand the factors that can impact its price. As of today, the current price of Coya Therapeutics, stands at 6.52, as last reported on the 30th of November, with the highest price reaching 6.75 and the lowest price hitting 6.31 during the day. Coya Therapeutics, appears to be moderately volatile, given 3 months investment horizon. Coya Therapeutics, Common secures Sharpe Ratio (or Efficiency) of 0.048, which signifies that the company had a 0.048% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Coya Therapeutics, Common, which you can use to evaluate the volatility of the firm. Please makes use of Coya Therapeutics,'s Mean Deviation of 3.79, downside deviation of 6.3, and Risk Adjusted Performance of 0.0479 to double-check if our risk estimates are consistent with your expectations.
At present, Coya Therapeutics,'s Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 10.9 M, whereas Capital Stock is forecasted to decline to 1,369. . At present, Coya Therapeutics,'s Price Book Value Ratio is projected to slightly decrease based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.21, whereas Price To Sales Ratio is forecasted to decline to 10.04. Coya Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Coya |
Sharpe Ratio = 0.048
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | COYA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.99 actual daily | 53 53% of assets are less volatile |
Expected Return
| 0.29 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Coya Therapeutics, is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Coya Therapeutics, by adding it to a well-diversified portfolio.
Price Book 3.4709 | Enterprise Value Ebitda (6.21) | Price Sales 11.6287 | Shares Float 14 M | Wall Street Target Price 15.625 |
Related Headline
Fennec Pharmaceuticals Headline on 27th of November 2024
Disposition of 400000 shares by Hackman Jeffrey S. of Fennec... by Hackman Jeffrey S.
Filed transaction by Fennec Pharmaceuticals Director, Officer Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Coya Therapeutics, Valuation on November 27, 2024
It is possible to determine the worth of Coya Therapeutics, on a given historical date. On November 27, 2024 Coya was worth 6.44 at the beginning of the trading date compared to the closed value of 6.65. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Coya Therapeutics, stock. Still, in general, we apply an absolute valuation method to find Coya Therapeutics,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Coya Therapeutics, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Coya Therapeutics,'s related companies.
| Open | High | Low | Close | Volume | |
| 6.50 | 6.91 | 6.34 | 6.38 | 86,984 | |
11/27/2024 | 6.44 | 6.79 | 6.43 | 6.65 | 71,860 |
| 6.74 | 6.75 | 6.31 | 6.52 | 44,494 |
| Backtest Coya Therapeutics, | | | Coya Therapeutics, History | | | Coya Therapeutics, Valuation | Previous | Next |
Coya Therapeutics, Trading Date Momentum on November 27, 2024
| On November 29 2024 Coya Therapeutics, Common was traded for 6.52 at the closing time. The top price for the day was 6.75 and the lowest listed price was 6.31 . The trading volume for the day was 44.5 K. The trading history from November 29, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.95% . The overall trading delta against the current closing price is 1.35% . |
Coya Therapeutics, Common Fundamentals Correlations and Trends
By evaluating Coya Therapeutics,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Coya Therapeutics,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Coya financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Coya Therapeutics, Stock history
Coya Therapeutics, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Coya is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Coya Therapeutics, Common will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Coya Therapeutics, stock prices may prove useful in developing a viable investing in Coya Therapeutics,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 10.2 M | 10.9 M | |
| Net Loss | -11 M | -10.5 M |
Coya Therapeutics, Quarterly Net Working Capital |
|
Coya Therapeutics, Stock Technical Analysis
Coya Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Coya Therapeutics, Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Coya Therapeutics, Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Coya Therapeutics, November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Coya Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Coya Therapeutics, shares will generate the highest return on investment. By undertsting and applying Coya Therapeutics, stock market strength indicators, traders can identify Coya Therapeutics, Common entry and exit signals to maximize returns
Coya Therapeutics, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Coya Therapeutics,'s price direction in advance. Along with the technical and fundamental analysis of Coya Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Coya to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0479 | |||
| Jensen Alpha | 0.0656 | |||
| Total Risk Alpha | (0.69) | |||
| Sortino Ratio | 0.0259 | |||
| Treynor Ratio | 0.1648 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Coya Stock analysis
When running Coya Therapeutics,'s price analysis, check to measure Coya Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coya Therapeutics, is operating at the current time. Most of Coya Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Coya Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coya Therapeutics,'s price. Additionally, you may evaluate how the addition of Coya Therapeutics, to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |